Trial Profile
A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of NAFT-500 in Subjects With Tinea Pedis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Dec 2017
Price :
$35
*
At a glance
- Drugs Naftifine (Primary)
- Indications Tinea pedis
- Focus Therapeutic Use
- Sponsors Merz Pharma
- 17 Jun 2014 New trial record